Loading...
Loading...
Browse all stories on DeepNewz
VisitWhat will be the status of ACA's preventive services coverage after Supreme Court ruling by mid-2026?
All services maintained • 25%
Some services modified • 25%
Most services removed • 25%
Complete overhaul • 25%
Official ruling published by the U.S. Supreme Court or subsequent policy announcements
Supreme Court to Review ACA's No-Cost Coverage for Cancer Screenings, Heart Statins, and HIV Drugs
Jan 10, 2025, 11:26 PM
The U.S. Supreme Court has agreed to review a challenge to the Affordable Care Act's (ACA) requirement for no-cost coverage of certain preventive care services, including cancer screenings, heart statins, and HIV drugs. The case, Braidwood Management, Inc. et al. v. Xavier Becerra, questions the constitutionality of the U.S. Preventive Services Task Force's authority to mandate such coverage. The challenge stems from a ruling by the 5th U.S. Circuit Court of Appeals, which found that the task force's structure violated the Appointments Clause of the U.S. Constitution because its members are not appointed by the president and confirmed by the Senate. The Supreme Court's decision to hear the case could impact the availability of these preventive services, which are currently covered without cost-sharing under the ACA.
View original story
Remand to lower court for further proceedings • 25%
Strike down ACA coverage as unconstitutional • 25%
Uphold ACA coverage as constitutional • 25%
Other • 25%
No • 50%
Yes • 50%
Yes • 50%
No • 50%
Decrease in availability • 25%
Other • 25%
Increase in availability • 25%
No significant change in availability • 25%
No • 50%
Yes • 50%
Mixed outcomes • 25%
Increase in states restricting funding • 25%
Decrease in states restricting funding • 25%
No significant change • 25%
Other outcomes • 25%
Major repeal efforts • 25%
Minor adjustments • 25%
No changes • 25%
Rule in favor of South Carolina • 25%
Rule in favor of Planned Parenthood • 25%
Dismiss the case • 25%
Other outcome • 25%
Replaced by new measures • 25%
Extended as is • 25%
Allowed to expire • 25%
Other outcomes • 25%
No • 50%
Yes • 50%
Significant restriction of rights • 25%
Unclear impact • 25%
Significant expansion of rights • 25%
Minimal impact • 25%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
Yes • 50%
No • 50%
Full cost-sharing introduced • 25%
Coverage removed • 25%
No change • 25%
Partial coverage introduced • 25%